Regorafenib is a inhibitor that focuses on a few kinases, like VEGFR and TIE2. It’s used for treating metastatic colorectal cancer, GIST, and HCC. It comes in film-coated tablets, each containing 40 mg.
The usual dose is 160 mg, taken every day, for 21 days out of every 28-day cycle. Each pack has bottles with 84 tablets in them. The drug works on lots of cell and body processes to stop or slow down cancer cell growth.
